TY - JOUR T1 - Modulating the gut–liver axis and the pivotal role of the faecal microbiome in cirrhosis JF - Clinical Medicine JO - Clin Med SP - 493 LP - 500 DO - 10.7861/clinmed.2020-0676 VL - 20 IS - 5 AU - Charlotte Woodhouse AU - Arjuna Singanayagam AU - Vishal C Patel Y1 - 2020/09/01 UR - http://www.rcpjournals.org/content/20/5/493.abstract N2 - Cirrhosis is associated with intestinal dysbiosis, with specific alterations in the gut microbiota linked to particular aetiologies and manifestations of the disease. We review the role of the gut microbiome and the importance of the intestinal barrier in cirrhosis, provide an overview of the terminology and techniques relevant to this emerging area, and discuss the latest developments in therapies targeting the gut–liver axis. ER -